Added to YB: 2026-10-02
Pitch date: 2026-09-28
PMVP [bullish]
PMV Pharmaceuticals, Inc.
-5.84%
current return
Author Info
Trade Ideas Flow is an Ex-Equity PM & Quant (10y+ buy-side) curating the Open-Web Hedge Fund. Reading 100s of pitches weekly to find the signal. Sign up for the newsletter.
Company Info
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
Market Cap
$121.6M
Pitch Price
$1.37
Price Target
5.00 (+288%)
Dividend
N/A
EV/EBITDA
-0.54
P/E
-1.14
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
A barnacle fix Asia keeps buying - PMV Pharmaceuticals, Inc.
PMVP (quick overview): PMV Pharmaceuticals’ rezatapopt produced a 44% confirmed response rate and 10-month median response duration in heavily pretreated ovarian cancer, making the 4Q26 registrational analysis the key value inflection. A clean, on-time filing is framed as 350-500% upside versus 30-40% downside if the path breaks. The science is compelling, but the single-arm data, narrow mutation population and dilutive financing remain material weaknesses.
Read full article (2 min)